Main Web Site : www.henderson-morley.com

On line shop web site : http://www.herpesexpert.com (Frost and Simpson)

Investor Relations email : investors@henderson-morley.com

Henderson Morley is a drug discovery company

The company has been developed specifically to carry out preliminary sourcing and screening of candidates to combat diseases caused by the herpes family of viruses and certain other DNA viruses

Latest GECR update 15th October 2006

Latest GE&CR update - 15th Oct 2006 :


The news investors have all been waiting for - regarding negotiations with a US dermatological pharmaceutical firm has finally been unveiled. The licence has been granted under an agreement to
Cutanea, a U.S. pharmaceutical company, specialising in the development of dermatology products in the US market.

The licence is for new applications of ICVT for the treatment of dermatological conditions in humans. The agreement and takes the form of an exclusive American, Mexican and Canadian wide licence to bring products to market through a programme of pre-clinical and clinical development of treatments either by Cutanea or through a sub-licence. Under the terms of the Agreement, Henderson Morley will receive up to 6.675 million dollars in development and commercialisation milestone payments up to the point at which the application receives regulatory approval, and will receive royalties on net sales thereafter.

Under its business plan, Henderson Morley has stated its belief that, following clinical development and regulatory licence approval, sales of the product in excess of $1.5 billion could be achieved over the subsequent ten year period. This would give a potential royalty to Henderson Morley in excess of $115 million over this term.

As a drug discovery company, it is imperative that Henderson continues to grant licenses to further develop its technology portfolio. This is the group's third ICVT license agreement. Encouragingly, Cutanea has a great management team with a proven track record of commercialising dermatology products.

Meanwhile, the company has announced that it has been working away on a vaccine against Koi Carp Herpes virus. The group believes it is now ready to start field trials of a
candidate vaccine, in a collaboration with the Internationally renowned Hagerman
Aquaculture Research Institute in Idaho USA. The initial immunogenicity studies should produce results within 6 months, enabling Henderson Morley scientists to optimise the vaccine formulation, with a view to securing a product licence from the veterinary authorities as soon as practicable.

Clearly activity at Henderson Morley has been significant in recent weeks. The licensing announcement is very encouraging, but with the news now out of the way, the shares have eased - a classic case of buy on the rumour, sell on the news. That said, the stock has now pulled back below the recent placing price. With so much going on at the company, further newsflow in the shorter term is far from unlikely.

*Henderson Morley is a corporate client of Bishopsgate Communications which is owned by RSH, the ultimate owner of GE&CR.

Forecasts and a formal recommendation are suspended ahead of the publication of a detailed note next month.

HML Anyone know when the next update is due, its now lower than it was before the last RNS. Anyone any thoughts?

Looking like sentiment is changing but a bit early to say if HML can stay above 2p and move forward.AGM 14th November 2007 which may have some bearing on recent volume.Only have a relatively small amount of these from a few months ago so haven't looked in any great detail.Interesting though!

Hmmmm,looking good but will it last?

why should it?

exactly but then again why not? :-)

All depends on news as always...............

Maybe the long rumoured bid is just around the corner--it's certainly perking up!!

hi all

Hi holly not much action on here am afraid, am still holding these in the hope they may deliver something but it's a long painful wait
Some news on the ICVT should be due soon according to a RNS on the 20 June 2007, but don't hold your breath -)

RNS Number:6594Y
Henderson Morley PLC
20 June 2007

"It is envisaged that a final injectable formulation of ICVT will be ready
for Pre-IND discussions with the FDA by December 2007"

kkeith, its the Koi deal that everyones waiting for then 6/8p minimum which could come anyday.
Good luck.

is not SEO are better bet?

Brief research, though my weekend will be spent working on this suggests this could very well be highly lucrative solution if the KHV cure can be brought to market. These koi cost tens of thousands pounds each, the owner of the KOI farms would pay handsome rewards.

http://www.digitallook.com/news/rns/1038498-14431/HML-Scientific_Programme_Update.html

Could any person answer this simple question, are any other companies closer to bringing a cure to market than HML?

A simple search using the word KHV shows the devastation this disease causes. What a silly comment SEO are better. Like comparing a rover with a BMW. I enjoy finding these little penny stocks, I have massive concerns about those 3p spikes tones of ramping; I really hope that is not the case.

Good stuff

Olivergas, none what so ever. See Thefruits comments over on the ADVFN BB.

holly12345 thanks if you do a check he has flipped. i never believe what I read on BB's good for finding places to dig. I currently hold FRR, fweb, SEG and just bought some OHM. I think I will move a few K into HML. These penny stocks bring out the kid in me.

Oilivergas, TF knows more about HML than they do he's no ramper either.
KHV due any day now along with a certain Mr Dunne picking up a few more millions this year watch for largish buys coming in, you could catch it before the spike which this time around will not fall days after.

holly12345 reading the fruit bats posts on ADVFN shows he is clueless, his post yesterday on lse shows he is headless. Away from the rampers though one guy on lse posted last sunday seem to hold more hope and checking other threads his posted the same seems to suggest all is not lost read comments by Trading.Pirate, btw I do not know him but his comment breaths an air of hope I like. A few other comments on III suggest ramping but again with a hint of longer term news. I hope the rampers bog off and allow the stock to slowly rise

Fingers crossed Oilivergas.

LOL have a look at ecpc they have made a mistake RNS is giving .95 on the 29th whilst the share price is only .2

Oilivergas, khv' s on its way by the sounds of todays rns.

I don't like a strategic Review hanging about (since July07!), to make up their mind what to do. . . . Looks a bit like Eyes-off-ball . . . . meanwhile the sp drifts down.
Hardly a "speculative Buy" ( Thread subject). . . . ''loss'' is more like it.
This co has always been poor on information and the sp drift tells it all. I have a small holding now, from higher - but then so does everyone.

Sheering-Plough deal looks OK, but [HML[ needed to raise further capital at 0.6pence, so the sp has a new-low to reach.
The Sheering-Plough deal is for Koi-Carp treatment over three-years....so a thin coating of Jam (3-years hence).
-Obviously good news if you're a Koi-carp with a rather nasty infection . . . . . and can wait 3-years.
.....Oh dear......
EDIT..May08 ...Looks like the Company is attempting to keep investors informed, as regards future programmes, income and other "forward-looking" possibilities. Whilst this is not yet "income" it may at least align Company Bosses with expectations.... (ends)